Predictors of Early Remission of Hyperthyroidism in Children1
Abstract
Children with hyperthyroidism often require prolonged courses of antithyroid medication to achieve remission, and long-term compliance is problematic. To determine which clinical and laboratory features predict early remission, we reviewed the records of 191 patients less than 19 yr old with Graves’ disease. We compared patients achieving remission within 2 yr (group 1, n = 27) with those who completed more than 2 yr of medical therapy but did not achieve a remission (group 2, n = 79). Patients who were in neither of the above categories (n = 85) were excluded from the statistical analysis. Variables that were measurable at the time of diagnosis, recorded in more than 50% of the study population and associated with early remission in the univariate analysis (P ≤ 0.05), were entered into a stepwise multiple logistic regression analysis. Variables retaining a significant association with early remission (P < 0.05) were considered independent predictors of early remission. Patients achieving early remission were older (mean, 12.5 vs. 10.9 yr, P = 0.039) and had higher body mass indexes (BMI, 19.0 vs. 16.6, P = 0.002), higher BMI sd scores (−0.03 vs. −0.60, P = 0.004), lower heart rates (110 vs. 121, P = 0.023), smaller goiters (group 1: 60% with moderate/large goiter; group 2: 83%, P = 0.050), lower platelet counts (272 vs. 339 K/μL, P = 0.006), lower serum T4 and T3 concentrations at presentation (T4: 18.3 vs. 22.5 μg/dL, P = 0.015; T3: 439 vs. 613 ng/dL, P = 0.008), and were less likely to have a positive test for thyroid stimulating Igs (group 1: 50% vs. group 2: 93%, P = 0.008). Regression analysis identified BMI sd score and goiter size as independent predictors of early remission (P < 0.05). Eighty-six percent of patients with BMI sd score above −0.5 sd and minimal/small goiters achieved early remission, compared with 13% of those with BMI sd score below −0.5 sd and moderate/large goiters. We conclude that, of multiple clinical and laboratory variables associated with early remission, BMI sd score and goiter size are independent predictors. Algorithms employing these two variables can be used to facilitate counseling of patients and expedite therapeutic decisions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In another large cohort of 184 medically treated children, after 1 year of therapy with ATDs, 10% were in remission; after 2 years, 14%; after 3 years, 20%; and after 4 years, 23%.
“In another large cohort of 184 medically treated children, after 1 year of therapy with ATDs, 10% were in remission; after 2 years, 14%; after 3 years, 20%; and after 4 years, 23% (339,342).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [342]
Other studies of larger cohorts of pediatric patients with GD treated with ATDs for extended periods have not revealed similar remission rates.
“Although two decades ago it was suggested that 25% of children with GD go into remission with every 2 years of continued treatment (341), other studies of larger cohorts of pediatric patients with GD treated with ATDs for extended periods have not revealed similar remission rates (333,339,342).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [342]
Cites
The Management of Hyperthyroidism
Wood, A. J. J., & Franklyn, J. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406163302407 · Cited by 303 · see citing works
Administration of Thyroxine in Treated Graves' Disease
Hashizume, K., Ichikawa, K., Sakurai, A., Suzuki, S., Takeda, T., Kobayashi, M., Miyamoto, T., Arai, M., & Nagasawa, T. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241403 · Cited by 214 · see citing works
LIPPE, B. M., LANDAW, E. M., & KAPLAN, S. A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1241 · Cited by 192 · see citing works
Allannic, H., Fauchet, R., Orgiazzi, J., Orgiazzi, A., GENETET, B., LORCY, Y., GUERRIER, A. M. L., Delambre, C., & Derennes, V. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-3-675 · Cited by 192 · see citing works
REINWEIN, D., Benker, G., Lazarus, J. H., & Alexander, W. D. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501160 · Cited by 181 · see citing works
Feldt‐Rasmussen, U., Schleusener, H., & Carayon, P. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.1.8288723 · Cited by 167 · see citing works
Schleusener, H., Schwander, J., Fischer, C., Holle, R., Holl, G., Badenhoop, K. W. J., Hensen, J., Finke, R., Bogner, U., Mayr, W. R., et al. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200689 · Cited by 161 · see citing works
McIver, B., Rae, P., Beckett, G. J., Wilkinson, E., Gold, A., & Toft, A. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340403 · Cited by 135 · see citing works
García-Mayor, R. V., Páramo, C., Cano, R. L., Méndez, L. F. P., Galofré, J. C., & Andrade, A. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03348811 · Cited by 69 · see citing works
Weetman, A. P., Pickerill, A. P., Watson, P. H., Chatterjee, K., & Edwards, O. M. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068938 · Cited by 62 · see citing works
Cho, B. Y., Shong, M. H., Yl, K. H., Lee, H. K., Koh, C., & Mln, H. K. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02269.x · Cited by 51 · see citing works
Buckingham, B. A. (1981) · American journal of diseases of children · doi:10.1001/archpedi.1981.02130260004003 · Cited by 48 · see citing works
Rittmaster, R. S., Zwicker, H., Abbott, E., Douglas, R. D., Givner, M. L., Gupta, M. K., Lehmann, L., Reddy, S. S. K., Salisbury, S. R., Shlossberg, A. H., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784084 · Cited by 48 · see citing works
Factors influencing the outcome of thyrostatic drug therapy in Graves' disease
Winsa, B., Dahlberg, P. A., Jansson, R., et al. (1990) · European Journal of Endocrinology · doi:10.1530/acta.0.1220722 · Cited by 46 · see citing works
Remission Rates of Children and Adolescents with Thyrotoxicosis Treated with Antithyroid Drugs
Collen, R. J., Landaw, E. M., Kaplan, S. A., & Lippe, B. M. (1980) · PEDIATRICS · doi:10.1542/peds.65.3.550 · Cited by 42 · see citing works
Short‐term treatment of Graves' disease with methimazole in high versus low doses
Jorde, R., Ytre-Arne, K., Störmer, J., & Sundsfjord, J. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb00914.x · Cited by 35 · see citing works
Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose
Edmonds, C., & TELLEZ, M. U. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310120 · Cited by 34 · see citing works
Prediction of relapse in drug-treated Graves' disease using thyroid stimulation indices
Ikenoue, H., Okamura, K., Sato, K., Kuroda, T., Yoshinari, M., Tokuyama, T., Nakagawa, M., & Fujishima, M. (1991) · European Journal of Endocrinology · doi:10.1530/acta.0.1250643 · Cited by 32 · see citing works
Remission in Children With Hyperthyroidism Treated With Propylthiouracil
Gorton, C. (1987) · American journal of diseases of children · doi:10.1001/archpedi.1987.04460100062026 · Cited by 28 · see citing works
Werner, R. S., Romaldini, J. H., Farah, C. S., WERNER, M. C., & Bromberg, N. (1991) · Thyroid · doi:10.1089/thy.1991.1.293 · Cited by 25 · see citing works
DQA2 U ALLELE: A GENETIC MARKER FOR RELAPSE OF Graves'DISEASE
Ratanachaiyavong, S., Gunn, C., Bidwell, E. A., et al. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00860.x · Cited by 16 · see citing works
The weight of normal thyroid glands in children.
Kay, C., Abrahams, S., & McClain, P. E. (1966) · PubMed · Cited by 15 · see citing works
Tajiri, J., Noguchi, S., MORITA, M., et al. (1991) · Endocrinologia Japonica · doi:10.1507/endocrj1954.38.683 · Cited by 12 · see citing works
Variation in the morphometry of the normal human thyroid in growth and ageing
Roberts, P. F. (1974) · The Journal of Pathology · doi:10.1002/path.1711120306 · Cited by 12 · see citing works
Perozim, L. M., Lima, N., Knobel, M., et al. (1993) · PubMed · Cited by 5 · see citing works
de Rave, S., Hm, G., Bravenboer, B., et al. (1991) · PubMed · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
“Although two decades ago it was suggested that 25% of children with GD go into remission with every 2 years of continued treatment (341), other studies of larger cohorts of pediatric patients with GD treated with ATDs for extended periods have not revealed similar remission rates (333,339,342).”
BackgroundBahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098 · see citing works
Dissimilar Hepatotoxicity Profiles of Propylthiouracil and Methimazole in Children
Rivkees, S. A., & Szarfman, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2546 · Cited by 177 · see citing works
Kaguelidou, F., Alberti, C., Castanet, M., Guitteny, M.-A., Czernichow, P., & Léger, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0842 · Cited by 173 · see citing works
Thyrotoxicosis in Prepubertal Children Compared with Pubertal and Postpubertal Patients
Lazar, L., Kalter-Leibovici, O., Pertzelan, A., Weintrob, N., Josefsberg, Z., & Phillip, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6922 · Cited by 162 · see citing works
Léger, J., Gelwane, G., Kaguelidou, F., Benmerad, M., Alberti, C., & the French Childhood Graves' Disease Study Group (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1944 · Cited by 144 · see citing works
Glaser, N. S., Styne, D. M., & for the Organization of Pediatric Endocrinologists of Northern California Collaborative Graves’ Disease Study Group (2008) · Pediatrics · doi:10.1542/peds.2007-1535 · Cited by 125 · see citing works
Self-citationBreuer, C. K., Solomon, D., Donovan, P., Rivkees, S. A., & Udelsman, R. (2013) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2013-1 · Cited by 49 · see citing works
Pediatric Graves’ disease: management in the post-propylthiouracil Era
Rivkees, S. A. (2014) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2014-10 · Cited by 46 · see citing works
“The collective literature indicates that remission rates in children are less than 25% following many years of ATD therapy [33-37] (Table 1).”
Background
- Authors
- Glaser, N. S., & Styne, D. M.
- Affiliations
- University of California Davis Medical Center (US)
- Corresponding author
- Styne, Dennis M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-06-01
- Volume
- 82
- Issue
- 6
- Pages
- 1719-1726
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2008056684
- Cited by
- 115
- References
- 26
- Citations by year
- 2023: 1 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 6 · 2018: 6 · 2017: 2 · 2016: 3 · 2015: 6 · 2014: 4 · 2013: 2 · 2012: 6
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Ophthalmology and Eye Disorders
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- Graves' disease, pediatric hyperthyroidism, early remission, predictors of remission, body mass index, goiter size, antithyroid drugs, thyroid-stimulating antibodies, heart rate, platelet count, age of onset, medication adherence, long-term outcomes, radioiodine therapy
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Female, Goiter, Humans, Hyperthyroidism, Infant, Male, Prognosis, Remission Induction, Time Factors, Body Mass Index, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review